Log In
Print this Print this

BreMel/rGel (scFvMEL/rGel)

  Manage Alerts
Collapse Summary General Information
Company Targa Therapeutics Corp.
DescriptionSingle-chain fusion construct of an antibody targeting tumor-associated gp240
Molecular Target Tumor-associated gp240
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Fusion protein

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today